Blood Medical Report NM

_d www. nmmedico I.com TREND ANALYSIS :PATIENT'S NA/ttE Dr Prem K Daryanani DATE zPRINT Z3t1?t202118:5 : lD :72 Years / M/ Pat-lD : 111267@04 PERTTANENT AGE / SEX 15189306 For : Platelet Count Visit Date t8t07t2019 28t06n021 l9l07D02t Bn2D021 Result Value 2,65.0 24E.0 259.O 250.0 :For Leucocytes Count Visit Date t8lo7l20t9 28/06n021 t910712021 nl0n02l Result Value s960.0 3930.0 4464.0 4100.0 Corporate Office: NM MEDICAL u iviurnbai - Jn of 14ih an,.i :;3r'r.i F{c, Khai (vr) ir4r.irrr,terr - i2. ltel :g1-22-43,42gslgFay.:g1-224342g$80 E lrune ' Fortaieza, cer':h':r Avgi-ue, l(alyari llagar. Fr;;re - 06 Tel : g1-20-2660 0505 Fax : 9.i-20-2060 0506 E IairOalOra - enrnnhia :fin.l..-A Air;rnrr D^-.r D,.,-^...1..- t^t..\\4

n Mumbai E Pune D Bangalore E Ahmedabad ffi www. nmmedicol.com llegistration ld : I I 1267 0 144 Registration Date/Time 23/l2D02l / 02:00PM Collection Date / Time Patient Name : Dr Prem K Daryanani Reporting Date / Time 2311212021 2:08:l0PM Referred By : Dr.Roy Sitesh Aee /Sex I2311212021 04:32PM T2Years /Male lnvestigation Observed Value Reference Range Low Normal Hish;.j Test Sample 120 -246 u/L LDH 163.00 sERur,r Kindty note change in ref.range ,:-rt:i. ( Mctlrod : Lactale to Pvruvaic (NADH)) : i:: NABL Accredited NISHAP Yt.- fied By @ Dr. Alefia Moiyadi Page I of I M.D. Consulting Pathologist n lnumbai - Jn of 14th and 33rd Rd, Khar (W), $/umbai - 52. Tet :91-22-4342BB8B Fax :91-22-4342 8880 NM MEDI.CAL i Puna - Fortaleza, Cenkal A,venue. Kalyani Nagar, Firne - 06 Tel : 91 -20-2660 0505 Fax : 91 -20-2660 0506 [email protected] | \\,/t l/w.nmmedical.com n Bangalore - corporaie Bicck-A, Airport Road, Bangelc,re - 08. Tel : 91-80-4046 6464 Fax : 91-80-4015 6465

l{cgistration ld: Registration Date/Time /z 23112/2021 02:00PM i']irticrtt Name : Dr Prem K Daryanani Collection Date / Time :2311212021 zmIIIDs[ Reporting Date / Time i{cl'crrcd By : Roy Sitesh Dr Age /Sex :23112/2021 4:32:l6PM Sample Type: SERUM :72Years I Male TEST CRP (C-Reactive Protein) Quantitative Determination of CRP OBSERVED VALUE UNITS Reference Ranse Method : lmmunoturbidimetry mg/L 0-10 :* 12.OO - C-Reactive Protein (CRP) is an acute phise protein whose concentration rises non-specifically in response to inflammation. - CRp is seen to increase as a result of the inflammatory process,most notably in. response to Pneumococcal (bacterial) infection,histolytic disease and a variety of other disease states. - CRp is used as general diagnostic indicator of infections and inflammation,in addition to sering as a monitor of patient response to pharmacological therapy and s*u*rgeEryN. DOFREPORT ** NABL Accredited MANISHAP ffi wP Verified By Page I of6 @D-( Dr. Alefia Moiyadi M.D. Consulting Pathologist Corporate Ofrice: NAA MEDICAL n l''rii;m'aai - Jn of 'l4iir ::nr 3ljr',.i Rij, lftar ffi), ir'lr.iii'iar - i2. Tei:91-22.-4342 ggES Fax : g1-zz-4342 Bgg0 [email protected] I v,lww. n nt med ical. co rn E i-'ilile ' Fofialezar celli;al Ar.,i\"ri,:e, i(aiy,ani iriiigar pirire - 05 Tel : g1-2c-2660 0505 Fax : gi-20-2660 0506 I ir;angalorc. Corl]0iail i:ll,rrli-ii, Airtjori i-io.tl.:. ili: r,_;: ll;;c - 06. Tei : gj-90-,iC46 5464 Fax : g1-g0-40,16 6465

l{cgistration Id: 1112670144 Registration Date,/Time z23ll2l202l / 02:00PM !'atient Name : Dr Prem K Daryanani Collection Date / Time i{clc'rrcd By : RoY Sitesh Dr Reporting Date / Time :23/12/2021 2:08:lOPM Age /Sex :23112t2021 5:34:32PM z7}Yeus / Male CBC Sample Type: EDTA Whole Blood OBSERVED VALUE UNITS Reference Ranqe /c.mm 4000' 10000 TEST : 4100 Leucocytes Count mitt/c.mm 4.5 - 5.5 \\:(llod : Flolvcytomchy :* 3.63 gm% 13.0 - 17.0 Erythrocytes :* 10.3 % 4.0 - 50.0 il\"lcrirotl: Oplical :{' 33.0 ft Pg 83 - 101 llaemogtobin : 90.7 g/dt 27 -32 : 28.3 % 31.5 - 34.5 !i!.!lied : llrototnetricCN-Frce HB Method) 11.6 -',14.0 '.* 31.2 Packed Cett Votume 10 \" 3/c.mm 150 - 410 i 12.6 !1.'tix,d: Cfllculated : 250 fr 9.0 - 13 MCV '.* 6.4 h 40-80 l.:!:irod: Mcasurcd q 20-40 78 % 2-10 MCH .* 17 \\lc:irxi: Calculated 01 -06 5 00-02 MCHC liuiirod: Calculated 0 0 RDW \\:(rhod: Mcasured Ptatetet Count \\ictirotl : Optical MPV \\:.tirod: Mcas{rcd Neutrophits Lymphocytes Monocytes Eosinophits Basophits Microcytes Macrocytes Anisocytosis SONALI.G ffi &- Verified By Page2 of 6 NABL Accredited DR. ASHWNI K SINGH M.O.,D.P.B.,D.N.B @ Consulting Pathologist ,=( Ccrtilicate No: MC-3410 Corpora{e Otfice: Nr\\fl lv{EDlCAl- n irillnbai - Jn ci l rlih arrrr 3.3rri iid. Khai lVt4, i',l;n rir., : - 52. 1:el : 91-22-1342 E888 Fax : 91-22-4342 B88A [email protected] ilr I www. n nr rnedicai.c0rn 0E y;-111s - fo1slsz.r. Ce;rli'irll\\yeiiLe, Kaly.lni lri;rgai PL,r'te - ,el : 91-2C-2650 05'15 Fax .91-20-2660 A5li6 n ilenga!ore. CotirrraiL: ijiliii-A Aiipori Rrrail, Bc,,rj: lo;e - i.t8. Tel ;91-80-10466454Far:91-60-4046 6465

ricgistrationld: 1112670144 Registration Date/Time 223/1212021/ 02:00PM Coltection Date / Time :23112/2021 2:08:l0PM l'aticnt Name : Dr Prem K Daryanani Reporting Date / Time ;23112/2021 5:34:32PM l{cl'crrcd By : RoY Sitesh Dr Age /Sex :7?Years I Male Poikitocytosis Hypochromia ** END OF REPOM I'* NABL Accredited SONALI.G Page 3 of6 & Verified By ,.6ft. DR. ASHWNI K SINGH M.D.,D.P.B.,D.N.B 6\\,V=f/f(i') Consulting Pathologist Certificatc No: MC-3410 Corporate Office: NAil MtrDIC,rrL n :iriLrmbai - Jn oi'i.i.ih i:iril :J-'lr{ Rd, i(har i',ry), ilr-rir 1:-, - ?-.Tel:91-22-434288E8ta,\".:91-22-4342-BBB0 info(Onmmedical.com I wurw nmmedical conr n irung-Fortaleza,Oer'ii'al Av+rrue, l(al'/arri l'lri;ar Pr:n.\"-C6Tel :91-2C-26600505Fax:91-2C-266C0506 n ii;irnrralois - Corircraiii iiiniti,-.1-i,,.ririr0ri Ro:r(:. Bil,tir',iorb - 0i1. Tei : 9i-80-4046 6+64 Fa)( : f i-Att-4046 61165

i{egistration Id: 1112670144 Registration Date/Time 223/l2D02l / 02:00PM i'aticnt Name : Dr Prem K Daryanani Collection Date / Time itcltrrcd lly : RoY SiteshDr Reporting Date / Time z23112/2021 2:08:lOPM z23112/2021 5:34:32PM Age /Sex ;72Years / Male Malarial Parasite Antigen Test Sample Type: EDTA Whole Blood OBSERVEDVALUE Reference Ranqe : Negative TEST : Negative Negative Ptasmodium fatciParum antigen Negative Ptasmodium vivax antigen Method : Rapid lmmuno Chromatography Technique. INTERPRETATION: . It.This is only a screening test.The results of the test are to be interPreted with in the epidemiological, clinical therapeutic context. malarial infection. False Positives may be seen due to cross reactivity & persistence 2.A positive result indicates Antigenemia. 3.False negatives may occur due to high an:Ttig*eEneNmDiaO' F REPORT {.* NABL Accredited SONALI.G ffi & Verified By Page 4 of 6 ,€h\\ DR. ASHWNI K SINGH M.D.,D.P.B.,D.N.B 6\\-vf,f'/i8 Consulting Pathologist z,z--\\ Corporate Office: N,U T'/EDICAI tr ilumbai -Jnof 'l4ihand::3r,lRd,Kharl,i\\l). lvlunrba -52.iti:91-22-43428888Fax:91-22-43428880 infc@n m meCical.com I v'ir,vw. nmmedical.conr E ;rune - Fo(aleza, Cerrir;iAri;,nue, Kal;ra6i i'.16gor Fr-;rre - 05 Tel :91-20.266A 0505 Fax :91-20-2660 0506 E naiigalore - Cor'pora'le ,iticli.A Ai,oori RD?d. lli:y;g:. iosg - 06. Tel : 9l-aij-404,5 6454 Fax :91-80-4046 6465

Itcgistration Id: 1112670144 Registration Date/Time :23112/2021 / 02:00PM i'eticnt Name : Dr Prem K Daryanani Collectiou Date / Time tirl'crrcd lly : Roy Sitesh Dr Reporting Date / Time :23112D021 2:08:l0PM Safiple Type: SERUM Age /Sex :23/l2D02l 4:40:2lPM TEST :'l2Years I Male Ferritin Ferritin Method OBSERVEDVALUE UNITS Reference Ranee : 10.50 [Rechecked] ng/mt 22-322 : CLIA - About two-thirds of the iron stores in the human body exist in the form of ferritin. . Ferritin provides a more sensitive,specifi!c*a*ndENreDliaObFleRmEePaOsuRreTme*n*t for determining iron deficiency at an early stage. NABL Accredited PRAMILA Page 5 of6 * Ccrtificate No: MC-3410 Verified By Dr. Alefia Moiyadi M.D. Consulting Pathologist Corporate Office: NM MEDICAT C llumbai - jno[14ihanil 33rdRd,Khar(W), l,4rtrioai: - iT.Tet:91-ZZ434ZBBBBFax:91-?2-4342AAE| [email protected] J v;ww.nqmedicai.com E i:trna' Fortaleza, cenirii Avenue, Kalyani Niagar pi:re - 06 Tel : 91-20-2660 0505 Fax : 91-20-2660 0506 ! iiangalore \" Ccrparai.,:3iock.A. Airpori RoaC, Br;,o:i1:s.c - 1lf . Tel : I l-8C-4046 646\"1, Fax : g j -80-4046 6465

iicgistration ld: 1112670144 Registration Date/Time 23ll2D02l / 02:00PM iluticnt Name : Dr Prem K Daryanani Collection Date / Time i{cl'r'rrcd By : RoY Sitesh Dr Reporting Date / Time 23/1212021 2:08:10PM 23/1212021 6:56:47PM Age /Sex T2Years / Male b Deneue NSl Antieen Reference Ranqe Sample Type: SERUM OBSERVED VALUE Negative : Betow 0.9 Equivocal :0.9 - 1.1 TEST : NEGATIVE (0.02 ) Positive : Above 1.1 NS1Detection of Dengue Virus antigen in the given patient-s serum METH0D: ENZYME IMMUNO ASSAY (E.l.A) r13Zlen...pTDltaerhetireemnpdgamruerseoyteasvrqdtoiirueotuyinntspog:e-uibsseoaorvnffirelaudvseainviigninrufugiecsutevifoiorvnuuisrnueidssse,clasharagn(sredaelyctrrotaeintnyrsipzameereidsa1ss-bi4oyo)nfectalihesuvesbaeyttriodomneposnicsgqiunauenistdfope,esvcupeibrfril,-nctcraoNipsp5aei1clYlsyae.nreATtieghfdleeuenr'selilkeaaevereegillyslfnop-0uteisrtaosdn' id9stAdinadcyestdbeausftteaarlbntohtipgeiecontunicssaeltlyof days.symptomys; this generally persists upto '15 ^-,4.Earlier diagnosis of Dengue reduces risk of as or e-s--p-e-c!i-arl-ly. !in- C-^o.u.-n+tr;ie^s. rW^,hhearrae rd{eanngorurea iis( complication such DHF DsS, let#HJJ.:{ed55n.e.TFdfihaenilmssiteiivicsep. soonsdliytiiavagensorcesrseisue,lnttsihnegcaptneasbttieeanontbdtcalwiinniilecl daolndhluyiesitntoodriycc,arotsesysmthip\"et\"o\"mptiraoetsnoelonwEcieythoaMr: uawrbersalelynaVcseasloelerfoyDloaegnnidgcuaeel ndcNaeStpalhasahnliottiiugsle,dnJbaienpactnhoeenssesidpeeenrcecimedpe'hna' lFitoisr' a yettow flver and West Nile viruses. This occurs in the sample tested' NABL Accredited NEETA L ffi wP Ccrtificate No: MC-3410 Verified By Page 6 of6 Dr. Alefia MoiYadi M.D. Consulting Pathologist Corporate Office: Nh4 MEDICAL tr itrl,_rmbai . Jn of i.!iir arirl :l3tl Rr:i. t(har ($,t1, iUr_iirb:,:i - 52. lti:9i-22-43428808Fax:91-22-43428880 [email protected] | !yw\\iv. nmmedical.c0m E Puire. Fortaleza. CenirslA/enue, l(alyani I'lrgerr' ijr:ne.05 Tel :9'1-20-2660 0505 Fax:91-20-2060 0506 tr :3airgalore - Coqicratlr 3iccli.A, Airpori RoeC, Brrrlliore - 06 Tel : 9'1-30-,1046 $464 Fax: 91-EC-4046 6465

-}.i ;w!/ld. r')m medicol. com TREND ANALYSIS :PATIENT'S NA,r E rr,1r. prem Daryanani DATE zPRINT 13t12t207115:C SEX : lD zAGE / 73 Years / M/ Pat-lD :1112570090 PERI,iANENT 153454OQ :For Prostate Specific Antigen,Serum Visit Date 04/nnoD $t$n020 t3l02D02t Blnn02t Result Value 0.0 0.1 0.0 0.2 Corporate Office: l''.1il/ t4tDlcAL tl illumbai - Jn of 1 4th and 33rcl Rd, Khar (w), iviumbai - 52. Tel : 91-22-4342 BBBB Fax :91-224342 BB80 infrt/61nm,'npdir:rI nnm I r,rn,rllr nmmariir'tl r'r,rn E Pune - Fortaleza, central Avenue, Kalyani Nagar, puna - 06 Tel :91-2a-2660 0505 Fax : 91-20-2660 05(]6 E Eairgalore ' Corporaie Block-A, Airpori Roacl, 83n.icllr.i - i,ii. i,:.i 9 t-3,1-rlrj46 640,i Fa:r : g l-g0.,ln4ii ri:i65

& 'ai Ilcgistration Id: ttl2570}9} Registration Date/Time /t3/12/2021 ll:28AM :Patient Name Mr. prem Daryanani Collection Date / Time B/nn02t ll:29:09AN Ileferred By : sonawalaF RDr. Reporting Date / Time Age /Sex t3n2/202t 2:13:52PM I73 Years Male Sample Type: SERUM OBSERVED VALUE UNITS Reference Ranqe ng/mt 0-4.0 TEST : 0.19 Prostate Specific Antigen,Serum Method : CLIA ! - lncreasing levels of PSA are associated v/ith Prostatic pathology;including prostatitis, benign prostatic hyperplasia (BpH) and cancer of the prostate. ENDOFREPORT {.* ffiNABL Accredited PRAMILA w \\2w=e/'( Verified By Dr. Alefia Moiyadi Certificati No: MC-3410 M.D. Page I ofl Consulting Pathologist Corporate Office: tr itlumbai ' Jn of 14th and 33rd Rd, Khar(w), Mumbai - b2. Ter:91-22-43428888 Fax: 91-22_4342BBgo EI Pune ' Fortaleza, central Avenue, Karyani Nagar, pune - 06 Ter ; 91-20-2660 0505 Fax : 91-20-2660 0506 NM /VEDiCAL E Bangalore ' corporate Brock-A, Airpori Road, Bangarore - 08. Ter : 91-g0-4046 6464 Fax : 91-80-4046 6465 [email protected] j www.nmmedical.corur

,-ii ..::: r' PREM DAHYANANI rtRererence: Dr.snEM p6{i cal La firdh9tr.,vxofi,6p o ::::L-- ct Sample Collected At: Registered On: Dr hamresh v kalzunkar '::=:= r', PID NO: P112102398283 fifiA202104:08 PM Raut clinic OO9,ground floor morya bldg,s n o-----::'U::::: (= Ase: 7z.QYear(s) Sex: Male ghadi marg,chinchpokali,lalbaug,mumbai- Collected On: :E 1311212021 4:08PM 400013. zone: w-07a(25) ---...::.:F PROCESSING LOCATIONT Metropolis Reported On: Healthcare Ltd, unit No.409- 4'!6, 4th -_-::+ Floor, Commercial Building-l, Kohinoor 161121202102:11 PM Mall, Mumbal-70 -:\":- F :-:F GBC Haemogram inveptigation Observed Value Unit Biolooical Reference lntervdl Etvlbtsevles Haemoglobin (Hb) 10.1 gn/dL 14-18 t Erythrocyte (RBC) Count 3.48 mill/cu.mm 4.4-6.0 PCV (Packed Cell Volume) 30.7 1o 42-52 MCV (Mean Corpuscular Votume) 88.3 fL. 82-'101 pg MCH (Mean Corpuscular Hb) 29.1 g/dL 27-34 31.5-36 MCHC (Mean Goipuscular Hb Concn.) 32.9 RDW (Recl CeltDistribution Width) 14.5 otof 1 1.5-14.0 RBC Morphology . NormochromicNormocytic 4300-10300 Hemark 2000-7000. 1000-3000 LeueoeYles 4,300 cells/cu.mm 200-1000 Total Leucocytes (WBC) count 20-500 20-1 00 Absolute Neutrophils Count. 1806 /c.mm 40-80 Absolute Lymphocyte Count 1978 /c.mm 20-40 344 lc.mm 2.0-10 Absotute Monocyte Count 129 /c.mm 1-6 Absolute Eosinophil Count 43 /c.mm Absolute Basophil Count 42 % o2 Neutrophils 46 olol 140-44A Lymphocyte I otot 7.8-11 0.2-0.5 Monocytes 3 o1 9-17 TO Eosinophils l 1 % Basophils 2g2 a.e 10^3 / pl Platelels 0.159 fL Platelet counl 16.4 otol MPV (Mean Platelet Volume) t6 . PCT ( Platelet oit) PDW (Platetet Distribution Width) i\\otc:- Kindly note change in reference ranges. ' Dr. Saniay Gohil ./ \" . Paqe'! of t.Z. M.D. Pathologist HOD H'*::fir!:aiitd\\.6-l'vltAf F) fr fes.noa hdar MBL scope '*R.feftd lerr COLLEGE of AltERICAN PATHOIOGISIS EI'*NER F{EALTH RA/EALED

a Rererence: Dr.srrEgilnCi cal LalhB,rflfi$fgsB6po rt i -, . PREMDARYANANI Sample Collected At: Registered On: Dr hamresh v kalzunkar 13112t202104:08 PM - '*:: C:) PtD NO: P1'12102398283 -::E4..,,;-< l.) Age 7Z.OYea(s) Sex: Male Raut clinic 009,ground floor morya bldg,s n Collected On: -l :.:- ghadi marg,chinthpokali,lalbaug,mumbai' 13112120214:08PM 400013. zone: w-07a(25) RePorted On: _: c\\ PROCESSTNG LOCATIONT lletropolis $nA202102:'ll PM '::f Heatthcare Ltd, Unit No,409'416, 4lh Floor, Commercial Building'l, Kohinoor Mall, Mumbai-70 :ii:orDacTcumAsionwggrh,awomBlesCB\"alron\"ood,\"-oTri,et\"rse*t.srJJdJnoojinaneffiivor&nir'\"ACiu;[trnonmoictaortogesydcimFoiv[pieceaopiaatirn.tircCiette/.Flrl.ltCoii\"owtunctoecrrjv.mt(oRimsBCebatrasine.nddePosnliaataieepleipatrloccxouiumlaltatelbeiylypim1a0pia,e0md0ae0nteccrees/l)Hls'Ay' dllroAdbynnoarmmiacl Dr. SaniaY Gohil Hg:A:g:d'm::-:ec' tR\\['ta/---D\\qvDArIDI-aPY':/: tu.o. raitn-olosist HoD cgLtEGE orAMERlcaN PATHoLoclsrs PaogfipJ ol?,*on*uadtol^tnso ;:::;:::::ff:T\"H:{::#;:n'*\"*\";:zxili:#:xi\":'xmtrffi';,\"\", * rd rcr und.r NAEI kope i+Refed;d rerr INNER FAEALTH RIVEAIED

'00 PHEM DARYANANI Refeieirce: DT.SITEFllGCftlcal L @r?oR€P o rt *5 Sample Collected At: Registered On: afoi P1 12102398283 Dr hamresh v kalzunkar 13fiA202104:08 PM Raut clinic 0O9,ground floor morya bldg,s (r\") n ghadi Collected On: $ Age: 72.0Year(s) Sex: Male marg;chinchpokali,lalbaug,mumbai- finA21214:08PM $l 40001 3. zone: w-07a(25) Reported On: PROCESSING LOCATIONT MetroPolis Healthcare Ltd, unit No.409:416, 4th 1611U202102:11 PM Floor, Commercial Building-1 , Kohinoor lrvesligalie! Observed Value Unit Biological Reference 87 mg/dL lnterval t Normal:70-100 Glueose fasting lmpaired Fasting Glucose (lFG):100-125 (Plasma-F,UV Hexokinase) Diabetes mellitus: >= 126 (on more than one occassion) (American diabetes association guidelines 2021 ) BUN-Blood Urea Nitrogen 9'2 mg/dL 8-23 (Serum,Urease) Remad(: ln blood, Urea is usually reported as BUN and expressed in mg/dl. BUN mass units can be converted to urea mass units 'oy multiplying by 2.14. creatinine 0.63 mg/dl 0.90-1.30 (Serum,Jafles method(IDMS TRACEBLE)) lnterpretation - Creatinine is a wdste product formed in muscles from the high energy storage compound, creatine phosphate' The amount of creatinine produced is constant (unlike Urea) and is primarily a function of muscle mass. i)hysiological factors affecting serum creatihine concentration includes age, gender, race, muscularity, exercise, Pregnancy, certain orugs, diet, dehydration and nutritional status. Lovi serum Creitinine levels is seen in cases of low musclq mass like muscular atrophy, or aging. t{igh serum creatinine levels is seen in Acute and Chronic kidney disease., obstruction. Sirice a rise in blood creatinine is observed only with marked damage of the nephrgns, it is not suited to detect early stage kidney ciisease. Uric Acid ffi. mg(L '3.4-7.0 (Serum,Uricase) 8.7 mg/dl E.8-10.2 Calcium (SEIUM,NM.BAPTA) : 3.7 mg/dL 2.5-4.5 Phosphorous (serum,Molybdate UV) mmoyLSodium IlU 136-145 (Serum,lSE lndirect) Sodiumis the major extracellular cation and functions to maintain fluid distribution and osmotic pressure. Some causes of ecreased levels of sodium include prolonged vomiting or diarrhea, diminished reabsorption in the kidney and excessive fluid retention. Common causes of increased sodium include excessive fluid loss, high salt intake and increased kidney reabsorption. Potassium 4.3 mmoul 3.5-5.1 (Serum,lSE lndirect) Potassium is the major intracellulir cation and is critical to neural and'muscle cell activity. Some causes of decreased potassium icvels include reduceid intake of dietary potassium or excessive loss of potassium from the body due to diarrhea, prolonged vomiting or increased renal excretion. lncreased potassium levels may be caused by dehydration or shock, severe burns, diabetic *.ctoacidosis, and retention of potassium by the kidney. Chlorides 95 mmoUl 98-107 (Serum,lSE lndirect) Chloride is the major extracellular anion and serves lo regulate the balance of extracellular fluid distribution. Similarly to the other Dr.SAI{JAYGOHIL ,iii::iL.^,AA ff')12fhit k.MDuaer g@@td n ,/ Page 3 of M.D. Palhologist HOD Haematotogy '::ii,!: Med.d Pte?n,DErlo@r. , nf O tf E DV di<ol &ognostuicqod thdhasbecn w/,dokdby onhthoicd C.C. . fhercpoddo5ntneedPrytkors,gndeR.rulB r.lo.ontfb,,rcffiPlcc.reircd.Refaroconditimofftponhgofttkof.A + Iesmot under NASL 5<op€ **R.fetcd lctt COLIEGE oTA,MERICAN PATHOLOGISTS INNEF, HEALTI.{ REVEALED

s:A- PHEM DARYANANI Reterence: or.srsfiGdrlcal L ort ::--i-its i4 PtD No: P112102398283 Sample Collected At: Registered On: Dr hamresh v kalzunkar 13112/202104:08 PM Aoe:. 7z.oYear(s) Raut clinic O09,ground tloor morya bldg,s n ghadi Collected On: marg,chinchpokali,lalbaug, mumbai- 1311212021 4:08PM 400013. zone: w-07a(25) Reported On: PROCESSING LOCATIONi MetroPolis Healthcare Ltd, Unit No. 409- 416, 4lh 16i12t202102:11 PM Floor, Commercial Building-1, Kohinoot G: * ions, common causes of decreased chloride include reduced dielary intake, prolonged vomiting and reduced renal reabsorption as we, as some forms of alkalosis. rncrea\"eJ cniJriue ,aiues are iouno i-n dehydrati6n, kidney failure, some lorms of aciooiiiino acidosis, high dietary or p\"i\"ntoii\"tri*iO, intaX\", and salicylate poisoning. ! BilirubinTotal. Direct, lhdirectSerum 0'29 mg/dL 0-1.2 Bilirubin'Total (Serum,Diazo method) tnterpretation : Z..1 Total Bilirubin is the sum ol the unconjugated and conjugated fractions..,Total Bilirubin is elevated.in hepatitis, cirrhosis, inheritedLnzyme deficilniies, and conditions causirig hepatic obstruction' niemofytic disorders , several is used to monitor diseases causing jaundice in the new-bom, fetalis Neonatal Bilirubin quantitation bhiefly effiroblastosis ( also caused haemolytic ilisease of.the newborn or HDN') fprootment7iattof.o1rZ.b[ildiru!b!:ih Serum.bilirubin concentrations greater encephalopathy or kerniclerus' 3. physiologic jaundice is seen at serum bilirubin conbentrations riinu'n hilat ,\"y u\" p\"inoiogi\". The primary concern is lhe Bilirubin-Direct 0.16 mg/dL 0'0-0'3 (Sorum,Diazo method) Note: Direct Bilirubin is elevated in conditions causing hepatic obstruction , hepatitis, cinhosis, several inherited enzyme oeiiciencies, and inherited defects in canalicular excretion. Bilirubin- lndirect 0.13 mg/dL 0.1-1.0 (Serum,Calculated) 6.20 s/dL 6.4-8.3 4.30 g/dL 3.2-4.6 Prglelos 1.90 g/dl- 1.8-3.6 2.26 1.1-2.2 Total Protein U/L 0-41 I U/L 0-40 (Serum,Biuret) 16 mg/dL Desirable: < 200 Albumin mg/dL Borderline High: 200-240 169 High: >= 240 (scrum,Bromocresol green) Normal: < 150 Globulin Borderline High: 150-199 High:200-499 (Serum) Very High: >= 500 A/G Ratio (Serum,Calculated) SGPT (ALT) (Seium,lFCC w/o pyridoxal phosphate activation) scor (AST) (Serum,lHA) !-!pidltollle2 Cholesterot-Total (Serum,Enzymatic) Triglycerides level 61 (Serum,Enzymatic) Dr.SAI{JAYGOHIL ,iii::,.-A DDT.SANJAYGOHIL ./ \\-/{[email protected]<rioglfd,oPiougeaRnooesesduls4rrccelooptofedotn1fr4tiheosMsobme'pD.lne'EosiPdEdaerii.€hddbo,RlflrolAfesurlidostrthH.dOMcoD.neddtiPwHrocfarccetphmmi@)aggcorltowgrl&loeoogt6 y4'i.i.;.C!.:.;.C:..R...E..DITEDv. S(ope* fcs nor undcr NASL fdn*ReF.rEd COLLEGE ofAMERICAN PATHOLOGISTS F.IEALTH REVEALED 'T{NER

(oo} PHEM DARYANANI Reference: Dr.SlTffifQf cal L dPr?oR€port t) Sample Collected At: Registered On: (r') PID NO: P112102398283 Dr hamresh v kalzunkar Raut clinic 009,ground floor morya bldg,s BhAzOzl04:08 PM (I.:\\ Age: 72.0 Year(s) Male n ghadi marg,chinchpokali,lalbaug, munbai- Collected On: (\\ 40001 3. zone: w-07a(25) 1311?20214:08PM PROCESSING LOGATIONi MetroPolis Reported On: Healthcare Ltd, Unit No. 409- 416, 4th rcnU202102:11 PM Commereial Building-l, Kohinoor HDL Cholesterol 55 mg/dL Major risk factor for heart (Serum, Homogeneous enzymatic colorimetric disease: < 40 Negative risk factor for heart assay) , disease: >= 60 Non HDL Cholesterol 114.0 mg/dL Optimal:< 130 (Serum,Calculated) Desirable: 130-159 Borderline high: 1 59'1 89 High:189-220 Very High: >=220 LDL Cholesterol 101.8 mg/dL Optimal: < 100 Near Optimal: 100-129 (Serum,Calculated) Borderline high: 130-159 High:160-189 Very High: >= 190 VLDL Gholesterol 12.2 mg/dL 6-38 1.85 2.5-3.5 (Serum,Calculated) 3.07 3.5-5 LDUHDL RATIO (Serum,Calculated) CHOUHDL RATIO {Serum,Calculated) Nole: Fleference lnterval as per National Cholestercil Education Program (NCEP) Adult Treatment Panel lll Report. VLDL,CHOUHDL RATIO,LDUHDL HATIO,LDL Cholesterol,serum,Non HDL Colesterol are calculated parameters 'HsCRP-High bensitivity CRP 0.59 mg/L q= t (Serurn,Nephelometry) lnterpretation: .1 High sensitivity C reactive protein (hs CRP) measurements may be used as an independent risk marker lor the identification of individuals it risk for future cardiovascular disease. 2. hs CBP when used in conjunction with traditional risk factors may be uselul as bn independent marker for prognosis ol recurrent events in patients with stable coronary disease or acute coronary syn{romes. 3. Patients with evidence of active infection, systemiq inflammatory processes or trauma should not be tested for cardiovascular risk assessment until these conditions are abated. lroaSkdBs,Setsm 32 Fg/dL 33-193 pg/dL 125-345 lron ru 250-450 trg/dL 14-50 (Serum,FerroZine) 404 o,ol UIBC* g (Serum,FerroZine) TIBC* (Serum.Calculated) Translerin Saturation (Serum,Calculated) lnterp-rgleliqn : . Lr! not utrdcr l,lABL Scope i*Refcftd f6t COLLEGE of AMERICAN PATHOLOGISIS INNTR F{EALTH REVEATED

PREM DAHYANANI Reference: . Dr.SlTffiSOl cal La ort ::F Sample Collected At: Registered On: :m Dr hamresh v kalzunkar 131121202104:08 PM Raut clinic OO9,ground floor morya bldg,s :U n ghadi Collected On: PID NO: P1 12102398283 marg,chinchpokali, lalbaug, rnumbai- 19t12120214:08PM Age: 72.0 Yea(s) Sex: Male Reported On: 400013. zone: w-07a(25) 1--F '161121202102:11 PM PROCESSING LOCATION:- Metropolis -r{ Healthcare Ltd, Unit No. 409- 416,4th Floor, Commercial Building-1, Kohinoor 1. Measurements of serum iron, TIBC and the percentage of iron saturatidn of transferrin are uselul screening tests for iron deficiency anaemia. il*\"r\"r, .\"162. iron exhibits significant diurnal variation and may transiently rise or reach reference values afler dietary or 3. fi::'#[:liJ!'oifi['',tT:1i\",?1?jir'rfh, ror iron dericiency is rost in the presence-or acute & chronic innammarory. t.h, e transferrin in the serum are significantly affected, and fall rapidly as part of process'es as th6 concentrations ol iron and acute phase response irrespective of the iron stores status in the body. 4. Hence, Concurrent measurement of the markers mentioned in the below interpretative table alongwith serum iron studies improves the diagnostic specificity for iron deficiency anaemia & also provides a reliable work up for microcytic hypochromic anaemia. Tests lron Deficiency Anaemia of lron overload . Hemogloblnopathy anaemia Chronic disease (Especially Trait) Serum lron Decreased Serum Total lron lncreased Decreased lncreased Normal Binding Capacity % Transferrin Decreased Decieased or lncreased or Normal Normal Saturation' Normal Serum UIBC lncreased lncreased or Normal Normal Decreased or Normal Decreased Normal Serum Ferritin Decreased Decreased or lncreased or Normal Normal Normal Serum Soluble lncreased Decreased Normal lncreased Normal Transferrin ieceptor Serum Hepcidin Normal lncreased Normal Normal Associaied Tests : 1. Serum Soluble Transferrin receptor 2. Serum Hepcidin Alkaline Phosphatase 75 u/L 40-129 (Serum,p-nitrophenyl phosphate(IFCC)) 13 u/L < 60 181 u/L 0-250 Gamma GT (GGTP) (Serum,Enzymalic IFCC) LDH-Lactate Dehydrogenase (Serum,Lactate-pyruvate(IFCC)) 79 u/L < 190 CPK-Creatinine Phospho Kinase (Serum,CK-NAC IFCC) interpretalion : The major sources oI CPK activity are skeletal muscle, myocardium & brain. CPK levels are useful for diagnosing and monitoring of myocardial inlraction (Ml) and myopathies such as progessive Duchenne muscular dystrophy.Exercise and muscle trauma can elevate CPK values. Presence of Macro CK may elevale CPK levels. ffff Px:#xx\"x,ffi llffpia*sIe::6x\":r;1H2:i\"l'fnf:Jf#Tt'\"[?H?:iil'\"3i'offin\"\",\",or';\"\"n\"A'iliciii'cCnTAoryioV, * Iest not undcrl.l{'8L Sopc **Reftred Icr COLLEGE ofAMERICAN PAIHOLOGISTS IINNER FIEALTH REVEALED

eoo PREM DARYANANI Reference:' Dr.StTffiS@l Cal L orqPG€p o rt ooom PID NO: P112102398283 Sample Collected Al: Registered On: Dr hamresh v kalzunkar 131121202104:08 PM (ft Raut clinic O09,ground floor morya bldg,s $ Age; 72.0 Yea(s) Sex: Male n ghadi 1311?20214:08PM $,1 marg,chinchpokali, lalbaug,mumbai- 1611212021 02:11 PM 40001 3. zone: w-07a(25) iPROCESS ING LOCATION Metropotis Healthcare Ltd, Unit No. 409- 416,4th Floor, Commercial Building-1, Kohinoor ln.v_es!Lge!!en Observed ValUe +rL Biological Reference 0.81 lnterval (MSeerrucmu)ry'' Serum bv ICPMS pg/L 0.21-1.3 Serum lnteryretation Mercury exposure can occur from-Dental amalgams, Broken Mercury toxicity is often manifested as Mental symptoms (insomnia,fatigue,poor short-term thermometers, barometers, contaminated sea food memory),tremor,stomqtitis,gingivitis,Gl and Renal disturbances consumption, preservatives thimerosal), Grain seeds treated with methyl .1 Whole Blood / Serum metal testing is used lor the detection of recent exposure or poisoning with the toxic element. However, blood metal levels in healthy subjects can vary considerably with expostire to the-particular metal present in the . diet and in the environment. 2. lt should be noted.that low or within acceptable levels in blood / Serum do not always exclude that the element is uninvolved _ in contributing to the patient's symptoms because certain elements may be sequesiered in tissues. '3. Lower metal levels.in patients. on follow+p imelipmlyintahtaetdthtehetotxbixciceleelmemenelnte.xp' osuie patients envirpnment or that the body has efficiently is reduced in the immediate . -1 Sample collection guidelines for trace elements in blood and urine. tnternational union of pure and applied chemistry clinical Reference 2. chemistry division commission on toxicology working party. Pure & Appl. Chem., Vol. 67, Nos e/s, pi. rsiS-reoe, i'99S.' Nutrient & toxic elements interpretative guide; metamatrix, USA,-201 i. nl\"ffir[*?LL?Thisb c*p*.r se.orro ^r*nfhe reDofr h6 nd n ed pttyskol sQnature. R.rdt rehte mty u tii * Id mt und.. MSL kop. *R.f.red fen II\\IqER HLqLTH RTVEATED

PREM DARYANANI Reference: Dr.S[EMedical L branadoft)tdrop o rt :l) Sample Collected At: Registered On: :-d .^ Dr hamresh v kalzunkar 13112/202104:08 PM Raut clinic OO9,ground floor morya bldg,s PID NO: P112'102398283 n ghadi Collected On: 1311212021 4:08PM Age: 72.0 Year(s) Sex; Male marg,chinchpokali,lalbaug,mumbai- Reported On: :f{ 40001 3. zone: w-07a(25) 16h42021 02:11 PM :F iPROCESSING LOCATION Metropolis : Healthcare Ltd, Unit No. 409- 416, 4th Floor, Commercial Building-l, Kohinoor invSSligelign Observed Value Unit Biolooical Reference Interval ESR - Eryttyocyte Sedimentation Rate 11 *T/f,|. 0-15 (EDTA Whole Blood) Methg{: Automated Westergren interpretation: .'I lt indicates presence and intensity of an inflammatory process, never diagnostic of a specific disease. Changes are more 2. significant than a single abnormal test. lt is a prognostic test and used to monitor the course or response to treatment of diseases like tuberculosis, bacterial 3. endocarditis, acute rheumatic fever, rheumatoid arthrilis, SLE, Hodgkins disease, temporal arteritis, polymyalgia rheumatica. lt is also increased in pregnancy, multiple myeloma, menstruation, and hypothyroidism. Prhisis*putssencno^*,o,Ed{il'.frnnt,m\".ftlbl#,iihffifib\"lnu**r*r*r*,Ii:l'.-C_A ,/ d AC C DVThe rePon d@ no? n'cd P'ryskol slndtorc. R..ults dote onry & dr. sdmplc os receircd. Refer to c ondnhn; * fes not undcr N/qBL Scop. **Refer.d fe5t re4orlng oncl.rf R E D IT E INNER HEALTH REVEAI-ED

{00} PREM DARYANANI Reference: or.sreMedi cal L brcrra*OftyoBreEeo rt t*) Sample Collected At: Regisiered On: Dr hamresh v kalzunkar 131121202104:08 PM (e} PID NO: P112102398283 Raut clinic OO9,ground floor morya bldg,s (r') n ghadi Collected On: Age: 72.0Year(s) Male 1311U20214:08PM C) marg,chinchpokali,lalbaug,mumbai- 40001 3. zone; w-07a(25) 1611A202102:11 PM nl PROCESSING LOCATION :- MetroPolis Healthcare Ltd, Unit No.409- 416, 4th Floor, Commercial Building-1, Kohinoor lnvqstigation Observed Value Unit Biological Reference 446 pdmL lntqrval Vitamin Bl2lGvel 197-771 (Serum,ECLlA) Note : Ghange in Method & Reference range lnteroretation : .1 Vit 812 levels are decreased in megaloblastic anemia, partialltotal gastrectomy, pemicious anemia, peripheral neuropalhies, chronic alcoholism, senile dementia, and treated epilepsy. 2. An associated increase in homocysieine levels is an independent risk marker for cardiovascular disease and deep vein thrombosis. 3. HoloTranscobalamin ll levels are a more accurate marker of active VitBl2 component. lnrerpretation Note : patients on Biotin supplement may have interf.erence jn some immunoassays. With individuals taking.high dose Biotin (more than s mg p\";;\"y) .rppr\".5[G, it least'8-hour wait tirhe before blood draw is recommended. Ref: Arch Pathol Lab Med-Vol 141, November 2017 TSI-l( Ultrasensitive) 3.60 ylU/mL 0.54-5.3 (Serum,ECLlA) Note : Change in Method & lnteroretation : Reference range. 1. AS per 'p(u-3b0lis%he) dthlaitneraAtbubreotat nCdMiInAte. rHnaelncvee,rifsicuagtgioenstesdtudbiieoslo, gTicSaHl values on Cobas by ECLIA method gives higher reference intervals for Roche ECLIA is 0.54-5.3 &mu;lU/ml vaLies Heterence: Clinical Chemistry 50:12, 2338-23,+4 eA04) and lnd J Glin Biochem (Apr-June 20141 29(2):189-195. AACE . (American association of clinical endocrinologist) recommends TSH BRI as 0.45 to 4.5 &mu;lU/mL 2. TSH results between 5.3 to 15 show considerable physiologic & seasonal variation, suggest clinical borrelation or repeat testing with fresh sample 3. TSH results between 0.1 to 0.54 require correlation with patient age & clinical symptoms. As with increasing age, there . are marked changes in thyroid hormone production, metabolism & its actions resulting in an increased prevalence of 4. itH'il[1\"tHj;\"-fliff;fi\",ty attered because or non thyroidat ittness tike severe inrections,tiver disease, renal and heart failure,severe bums, trauma and surgery etc . 5. Drugs that decrease TSH values e.g:L-dopa,Glucocorticoid Drugs that increase TSH values e.g lodine,Lithium,Amiodaro l'dote : irarients on Biotin supplement may have interference in some immunoassays. With individuals taking high dose Biotin (more than 5 rng per day) supplements, at least 8-hour wait time before blood draw is recommended. Ref : Arch Pathol Lab Med-Vol 14'1, November 2017 Free T4 1.08 ng/dL 0.93-1.7 Note : Change in Method & (Serum,ECLlA) Beference range. t Lst not urd€r MBL kope **Refcrcd Ic* CoLLEGE of AMERICAN PATHOLOGISIS INNER FIEATTH REVTALED

.-ii oo PBEM DARYANANI Relerence: or.sreDl€oli cal L ottpdrop o rt a5 Sample Collected At: Begislered On: Dr hamresh v kalzunkar 13/12/202104:08 PM (cf}r 5 PID NO: P112102398283 Raut clinic 0O9,ground floor morya bldg,s 1311A20214:08PM (1^l n ghadi Reported On: C) Age: 72.Q Year(s) Male marg,chinchpokali,lalbaug, mumbaF 1611U2021 02:11 PM 400013. zone: w-07a(25) N PHOCESSING LOCATIONi Metropotis Healthcare Ltd, Unit No.409- 416, 4th Floor, Commercial Building-1, Kohinoor lnterpletatien : Total T3 & T4 valuefmay also be attered in other conditions due to changes in serum proteins or binding sites pregnancy, Drugs (Androgens,Estrogens, O C Pills ,Phenytoin), Nephrosis etc. ln such cases Free T3 an'd Free T4 give coirected vaiiJes. Nole : Patients .on. Biotin supplement may have interference in some immunoassays. W1h individuals taking high dose Biotin (more than 5 supplements, at least 8-hour wait time belore blood draw is reiommended- ing per day) ilel: Arch Pathol Lab Med-Vol 141 , November 2017 Free T3 2.13 pg/mL 2.0-4.4 . Note : Change in Method & (Serum,ECLlA) Rererence range ldergelauen- I otal T3 & T4 values may also be altered in other conditions due to_changes in serum proteins or binding sites pregnancy, Drugs iAndrogens,Estrogens, o c Pills ,Phenytoin), Nephrosis etc. ln such casds Free rs inb FEe Ta give-;necteo values. Note : Patients.on.Biotin.supplement may-have interferencejn some immunoassays. wth individuals taking high dose Biotin (more lhan 5 [Rre9f.P: AerrcdhayP)asthuoplpLleambeMntes,d-aVt olela's1t418-,hNoouvrewmabitertim2e01b7efore blood draw is reiommended. 25 Hydroxy (OH) Vit D 55.8 ng/mL Deficiency: < 10 lnsutficiency: 10-80 (Serum,ECLlA) Sutficiency: 30-100 Hypervitaminosis: > 100 Note : Change in Method lntelpretation : '1 vitamin D is a fat soluble vitamin and exists in.two main forms as cholecalciferol(vitamin D3) which is synthesizeci in skin from 7-dehydrocholesterol in response to sunlight exposure a irgocircirerol(vltamln D2) present mainly in dietary sources.Both cholecalciferol & Ergocalciferol aie converteo to zsjorilvitamiri o in river. 32^'' srts,sDTsragyiueeegurennrseanrnudtil.tiiniemkrfngmiogitcghnimeca.t2dmnnerf5efottyaos(.xrocnspHct2iHaeoolooo5narr)swrrsvd(siueon(ieoterrcHgavaensaem)tpalevo&rcel,ii.i(lntuccedatoimrhsaimireDnepallti,yia.lon.cersrvreayceivqDtlmiryaaiuuii,nlmariiymisrtgaieaienwnbrdkpec.elieDenaeisdo.tlaiceouvmtFtirhsimui)omwaaemrgrmdieat,ddehnpieiinsandyff6eOigr-ecDerrniidu.vessovmirh.nOsiuetaciigcusssmyPegal'mipeTitiontnts,fHfopiatlsue.vDrrrde&ietit.hirnaOs\"esictmrue\"eiiinpbipsilrnnrgue.to-oipsminofn-lr'geieicihiioi\"prniroeJ!iriiefia.nri,a'Oidsrictriieii.iii]tne'ilnr-oc\"mune'gormcticrvniiorti92eraIionotsvt\"s(ieriasmtopoa9iHrrma9reeta)cricivvniihoibiaestimoearDeudvmom.eoyn?ieunirfsniatesrudtiD,trfe;ifiotisdaciisnufireafntaiinolL;ftet;s\"ehx\"tvDarap\"ivtto\"1aute,so2msuxcwmriialcneienasirteitDycaokpabbshilselstyavoocskieorrninpclressoartdiewotsmlnanhaftrtoh6iobowsimuvnitotywvf eitrhy Asgociated lest Profile : ' For diagnosis of vitamin D deficiency it is recommended to have clinical correlation with serum 2s(oH)vitamin D and serum IN!\\{ER I-{HALTH REVEALED

PREM DARYANANI Beference: Dr.strEldgdi cal L hrere*S73y6ft0dro rt ::F Sample Collected At: Registered On; Dr hamresh v kalzunkar :=<UAi-l Raut clinic 009,ground floor morya bldg,s fihA202104:08 PM n ghadi := ptD NO: p1j210239828s Collected On: = h:-r8 Age: 72.0 Yea(s) marg,chinchpokali,lalbaug,mumbai- Male 1311U20214:08PM 400013. zone: w-07a(25) Reported On: l'{. PROCESSING LOCATION:- Metropolis '1611212021 02:1'l PM Healthcare Ltd, Unit No. 409- 416, 4th Floor, Commercial Building-1, Kohinoor - PTH.An inverse relalionship exists between PTH and 25(OH)D levels, Parathyroid hormone levels start to rise at 25(OH)D levels below 31 nIlmL & uiually decrease after the corection of vitamin D insufficiency.Thus, restoration ol PTH and 25 (OH)D levels to n6rmalcy afier idequate vitamin D replacement therapy is a useful monitoring strategy' interpretation Note : i,atiehti on Biotin supplement may have interference in some immunoassays. With individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended. tlef : Arch Pathol Lab Med-Vol 141 , November 2017 Homocysteine 12.89 pmol/L 5.46-16.2 (Serum,CMlA) lnterplglalien : .'I lncreased levels are seen in deranged VilB12 metabolism and lorm an independent marker for risk ol thromboembolic episodes in coronary artery disease. 2. Levels are also increased in homocyteinuria, various neoplastic diseases like cancers of ovary or breast and Acute Lymphoblastic Leukemia, chronic liver or renal failure post menopausal state, drug usage, and cigarette smoking. PSA- Prostate Specific Antigen 0.214 ngiml Conventionalfor all oQes: <=4 70 -79 yrs: 0 - 6.5 (Serum,ECLlA) Note : Change in method and Reference range INTERPRETATION: Prostate-specific antigen (PSA) is a glycoprotein that is produced by the prostate gland, the lining of the urethra, and the bulbourethral gland. PSA exists in serum mainly in two forms, complexed to alpha-1-anti-chymotrypsin (PSA-ACT complex) and unbound (free PSA). lncreases in prostatic glandular size and tissue damage caused by benign prostatic hypertrophy, prostatitis, or probtate cancer may increase cirgulating PSA levels. Transient increase in PSA can also be seen following per rectal digital or sonological examinations. NOTE: Patients on Biotin supplement may have interterence in some immunoassays. With individuals taking high dose.Biotin (more than 5 mg per day) supplements, at least 8-hour wait time belore blood draw is recommended. t:lel: Arch Pathol Lab Med-Vol 141 , November 2017 * Icst oot urdc. NABI S@pe r*R€fe.red fes COLLEGE Of AMERICAN PATHOLOGISTS INNER FIEAI-TH REVEATED

:.-m Medical La.boratory Report PREM DARYANANI Reference: DT.SITESH ROY .<u VID:112110730003108 PID NO: P112102398283 I -::----:-::; cn Age: 72.0 Yea(s) Sex: Male SDar mhapmlereGsohllevcktead lAzut:nkar Begistered On: :U']:.:(= I :::(v) :N I 131121202104:08 PM Raut clinic 009,ground lloor morya bldg,s n I :-.U.-_F w-07a(25)ghadi marg,chinchpokali,lalbaug,mumbai- I Gollected On: 400013. zone: | 1311212021 4:08PM '---- C-.1 PBOCESSING LOCATIONT Metropolls I Reported On: .:F I '1il12J202102:11 PM Healthcare Ltd, unit No.409. 416,4th FMloalol,r,MGuommmberacial-l 7B0uilding-l, Kohinoor I I -F HbAIC- Glycated Haemoglobin, blood by HPLC method l (EDTA Whole Blood) lnvegligalion Observed Value U.nit Biolooical Reference lnterval 5.9 % HbAI C- Glycated Haemoglobin Non-diabeticr <= 5.6 Pre-diabetic: 5.7-6.4 (HPLG) Diabetic: >= 6.5 Refer interpretation for monitoring rang'es. Estimated Average Glucose (eAG) 122.63 mg/dL lnterpretation & Remark: '1. HbAlc is used lor monitoring diabetic control. lt reflects the eslimated average glucose (eAG). 2. HbAl c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 201 7, for diagnosis of diabetes using a cut-off point of 6.5%. 3. Trends in HbAlc are a better indicator of diabetic control lhan a solitary test. 4. Low glycated haemoglobin(below 47d in a non-diabetic individual are often associated with systemic inflammatory diseases, chronic anaemia(especially severe iron deficiency & haemolytic), chronic renal failure and fiv6r diseases. Clinical torelation' suggested. tr To estimate the eAG lrom the HbAIC value, the following equation is used: eAG(mg/dl) =2g.Z,A1c-46.1 b_ lnterference of Haemoglobinopathies in HbAlc estimation. A. For HbF > 25%, an alternate platform (Fructosamine) is recommended fortesting of HbAlc. BC..HHeotmeroozzyyggoouusshsetamteogdleotbeincotepdat(hDy10is/T{eotsehcoteGd8, ifsrcuoctrorseacmteindeforisHbreScaomndmHebnCdetrdaifto).r ionitoring diabetic status 7. ln known diabetic patienls, following values can be considered.as a tool for monitoring the glycemic control. Excellent Control -Glo7 Yo, Fair to Good Control -7 lo I yo, Unsatisfactory Control - 8 to 10 % and Poor Control - More than 10 7o . Note : Hemoglobin electrophoresis (HPLC method) is recommended for detecting hemoglobinopathy. -- End of Report -- INNER HEALTI.TI REVEALED